Celldex Therapeutics (CLDX) is emerging as a biotech name to watch, driven by its innovative antibody pipeline and promising late-stage trials. With strong clinical progress, a solid cash position, and growing investor confidence, the company is positioning itself at the forefront of treatments for severe allergic and inflammatory diseases.Company OverviewCelldex Therapeutics is a biopharmaceutica...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.